Estrogen is a hormone which exerts its effects in different physiological processes including the initiation and progress of inflammation. In addition to nuclear receptors, estrogen binds to plasma membrane receptors and activates signal transduction pathways. This study explores the role of calcium in estrogen regulated signal transduction from the plasma membrane. For this, Human Umbilical Vein Endothelial Cells (HUVEC) and monocytes (THP‐1) were treated with estrogenic compounds (200nM) and calcium labeled using a calcium green indicator and cells were visualized and measured using confocal microscopy. In THP‐1 cells and HUVEC cells, calcium decreased in the perinuclear cytoplasm. Decreases in Calcium were measured in THP‐1 cells treated with 17β‐estradiol (16 fold), Diethylstilbestrol (DES, 4 fold), Genistein (6 fold), and Daidzein (14 fold). Similarly, decreases were observed in HUVEC cells treated with 17β‐estradiol (9 fold), DES (1 fold), Genistein (3 fold), and Daidzein (6 fold). Overall levels of intracellular calcium were not altered. Thus, the changes in perinuclear cytoplasmic calcium may be due to the movement of calcium to the plasma membrane in response to estrogen treatments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.